» Articles » PMID: 25569433

Assessment of Incidental Findings in 232 Whole-exome Sequences from the Baylor-Hopkins Center for Mendelian Genomics

Overview
Journal Genet Med
Publisher Elsevier
Specialty Genetics
Date 2015 Jan 9
PMID 25569433
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: In March 2013 the American College of Medical Genetics and Genomics published a list of 56 genes with the recommendation that pathogenic and likely pathogenic variants detected incidentally by clinical sequencing be reported to patients. As an initial step in determining the practical consequences of this recommendation in the research setting, we searched for variants in these genes in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian Genomics.

Methods: We identified rare, nonsynonymous, and splicing single-nucleotide variants and insertions/deletions and assessed variant classification using the Human Gene Mutation, Emory, and ClinVar databases. We analyzed the burden of mutation in each of the 56 genes and determined which variants should be reported to patients.

Results: Our filtering resulted in 249 distinct variants, with a mean of 1.69 variants per individual. Half of these were novel missense mutations not classified by any of the three reference databases. Of 101 variants listed in the Human Gene Mutation Database, 48 were also in ClinVar and 3 were also in Emory; half of these shared variants were classified discordantly between databases. Some genes consistently had greater variation than others. In total, 0.86% of individuals had a reportable incidental variant.

Conclusion: These observations demonstrate some current challenges of assessing phenotypic consequences of incidental variants for counseling patients.

Citing Articles

Genes to therapy: a comprehensive literature review of whole-exome sequencing in neurology and neurosurgery.

Tan J, Awuah W, Ahluwalia A, Sanker V, Ben-Jaafar A, Tenkorang P Eur J Med Res. 2024; 29(1):538.

PMID: 39523358 PMC: 11552425. DOI: 10.1186/s40001-024-02063-4.


Analysis of 14,392 whole genomes reveals 3.5% of Qataris carry medically actionable variants.

Elfatih A, Saad C, Mifsud B, Mbarek H Eur J Hum Genet. 2024; 32(11):1465-1473.

PMID: 39020067 PMC: 11576737. DOI: 10.1038/s41431-024-01656-1.


Genetic Differences between Physical Injury Patients With and Without Post-traumatic Syndrome: Focus on Secondary Findings and Potential Variants Revealed by Whole Exome Sequencing.

Kang H, Lee H, Kim K, Kim J, Lee J, Kim S Clin Psychopharmacol Neurosci. 2021; 19(4):683-694.

PMID: 34690123 PMC: 8553524. DOI: 10.9758/cpn.2021.19.4.683.


Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.

Horiuchi Y, Matsubayashi H, Kiyozumi Y, Nishimura S, Higashigawa S, Kado N Hum Genet. 2020; 140(2):321-331.

PMID: 32710294 DOI: 10.1007/s00439-020-02207-6.


Reduced penetrance of pathogenic ACMG variants in a deeply phenotyped cohort study and evaluation of ClinVar classification over time.

van Rooij J, Arp P, Broer L, Verlouw J, van Rooij F, Kraaij R Genet Med. 2020; 22(11):1812-1820.

PMID: 32665702 PMC: 7605437. DOI: 10.1038/s41436-020-0900-8.


References
1.
Astejada M, Goto K, Nagano A, Ura S, Noguchi S, Nonaka I . Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan. Acta Myol. 2008; 26(3):159-64. PMC: 2949309. View

2.
Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. PMC: 2705234. DOI: 10.1093/bioinformatics/btp324. View

3.
Wang L, Guo D, Cao J, Gong L, Kamm K, Regalado E . Mutations in myosin light chain kinase cause familial aortic dissections. Am J Hum Genet. 2010; 87(5):701-7. PMC: 2978973. DOI: 10.1016/j.ajhg.2010.10.006. View

4.
Rodriguez-Garcia M, Monserrat L, Ortiz M, Fernandez X, Cazon L, Nunez L . Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy. BMC Med Genet. 2010; 11:67. PMC: 2880974. DOI: 10.1186/1471-2350-11-67. View

5.
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View